(S1 (S (S (NP (NN Lactoferrin)) (VP (VBZ enhances) (NP (NP (NP (NN Fas) (NN expression)) (CC and) (NP (NN apoptosis))) (PP (IN in) (NP (NP (DT the) (NN colon) (NN mucosa)) (PP (IN of) (NP (JJ azoxymethane-treated) (NNS rats)))))))) (. .)))
(S1 (S (S (NP (NP (JJ Bovine) (NN lactoferrin)) (, ,) (NP (DT a) (JJ multifunctional) (NN glycoprotein)) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (ADVP (RB strongly)) (VP (VB inhibit) (NP (NP (NN development)) (PP (IN of) (NP (ADJP (NN azoxymethane) (-LRB- -LRB-) (NN AOM) (-RRB- -RRB-) (JJ -induced)) (NN rat) (NN colon) (NNS tumors))))))))))) (. .)))
(S1 (S (S (NP (JJ Little)) (, ,) (ADVP (RB however)) (, ,) (VP (VBZ is) (VP (VBN known) (PP (IN about) (NP (DT the) (JJ inhibitory) (NNS mechanisms)))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN demonstrated) (ADVP (RB recently)) (SBAR (IN that) (S (NP (NN lactoferrin)) (VP (VBZ enhances) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NP (DT a) (NN member)) (PP (IN of) (NP (DT the) (NN tumor) (NN necrosis) (NN factor) (NN receptor) (NN family)))) (, ,) (NP (NN Fas)) (, ,))) (PP (IN in) (NP (DT the) (NN colon) (NN mucosa)))) (PP (IN during) (NP (NP (ADJP (CC both) (ADJP (JJ early)) (CC and) (ADJP (JJ late))) (NNS stages)) (PP (IN of) (NP (NN carcinogenesis))))))))))) (. .)))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NN Fas)) (VP (MD could) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (JJ bovine) (JJ lactoferrin-mediated) (NN inhibition)) (PP (IN of) (NP (NN tumor) (NN development))))))))) (. .)))
(S1 (S (S (VP (TO To) (VP (VB investigate) (NP (DT this) (NN possibility))))) (, ,) (NP (PRP we)) (VP (VBD studied) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (JJ bovine) (NN lactoferrin))) (PP (IN on) (NP (NP (JJ Fas-mediated) (NN apoptosis)) (PP (IN with) (NP (NP (NN regard)) (PP (TO to) (NP (NP (NP (NN expression)) (PP (IN of) (NP (NN Fas)))) (, ,) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NN caspase-8)) (CC and) (NP (NN caspase-3))))) (, ,) (CC and) (NP (NP (NN DNA) (NN fragmentation)) (PP (IN in) (NP (NP (DT the) (NN colon) (NN mucosa)) (PP (IN of) (NP (JJ AOM-treated) (NNS rats)))))))))))))) (. .)))
(S1 (S (S (NP (NN Western) (NN blot) (NN analysis)) (VP (VBD demonstrated) (NP (NP (NP (DT a) (NN >) (JJ 2.5-fold) (NN increase)) (PP (IN in) (NP (NN Fas) (NN protein) (NN expression)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NN elevation)) (PP (IN of) (NP (NP (DT the) (JJ active) (NNS forms)) (PP (IN of) (NP (CC both) (NP (NN caspase-8)) (CC and) (NP (NN caspase-3)))))))))) (. .)))
(S1 (S (S (NP (JJ Immunohistochemical) (NN analysis)) (VP (VBD revealed) (NP (NP (JJ Fas-positive) (NNS cells)) (CC and) (NP (JJ apoptotic) (NNS cells))) (ADVP (RB preferentially)) (PP (IN within) (NP (DT the) (JJ proximal) (NN colon) (NN region))) (, ,) (ADVP (RB clearly)) (PP (IN at) (NP (NP (DT the) (NN site)) (PP (IN of) (NP (JJ bovine) (JJ lactoferrin-mediated) (NN tumor) (NN inhibition))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN apoptosis)) (VP (VBN caused) (PP (IN by) (NP (NP (JJ elevated) (NN expression)) (PP (IN of) (NP (NN Fas))))))) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (NN chemoprevention)) (PP (IN by) (NP (NP (NN lactoferrin)) (PP (IN of) (NP (NN colon) (NN carcinogenesis))))))))))))) (. .)))
